mCRPC (Metastatic Castration-resistant Prostate Cancer)
16 clinical trials · Condition
◉ Watch mCRPC (Metastatic Castration-resistant Prostate Cancer)
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma (NCT03207867) | Novartis Pharmaceuticals | 2017-08-28 |
Track mCRPC (Metastatic Castration-resistant Prostate Cancer) automatically
Every clearance here is in the API, with alerts when new ones post.